1. Home
  2. JYNT vs ACHV Comparison

JYNT vs ACHV Comparison

Compare JYNT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JYNT
  • ACHV
  • Stock Information
  • Founded
  • JYNT 2010
  • ACHV N/A
  • Country
  • JYNT United States
  • ACHV Canada
  • Employees
  • JYNT N/A
  • ACHV N/A
  • Industry
  • JYNT Multi-Sector Companies
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • JYNT Miscellaneous
  • ACHV Health Care
  • Exchange
  • JYNT Nasdaq
  • ACHV Nasdaq
  • Market Cap
  • JYNT 163.0M
  • ACHV 159.0M
  • IPO Year
  • JYNT 2014
  • ACHV N/A
  • Fundamental
  • Price
  • JYNT $11.68
  • ACHV $4.50
  • Analyst Decision
  • JYNT Strong Buy
  • ACHV Strong Buy
  • Analyst Count
  • JYNT 2
  • ACHV 3
  • Target Price
  • JYNT $18.00
  • ACHV $14.00
  • AVG Volume (30 Days)
  • JYNT 57.1K
  • ACHV 87.9K
  • Earning Date
  • JYNT 11-07-2024
  • ACHV 11-07-2024
  • Dividend Yield
  • JYNT N/A
  • ACHV N/A
  • EPS Growth
  • JYNT N/A
  • ACHV N/A
  • EPS
  • JYNT N/A
  • ACHV N/A
  • Revenue
  • JYNT $120,071,078.00
  • ACHV N/A
  • Revenue This Year
  • JYNT $0.70
  • ACHV N/A
  • Revenue Next Year
  • JYNT N/A
  • ACHV N/A
  • P/E Ratio
  • JYNT N/A
  • ACHV N/A
  • Revenue Growth
  • JYNT 7.46
  • ACHV N/A
  • 52 Week Low
  • JYNT $7.31
  • ACHV $3.03
  • 52 Week High
  • JYNT $17.82
  • ACHV $5.98
  • Technical
  • Relative Strength Index (RSI)
  • JYNT 50.12
  • ACHV 52.58
  • Support Level
  • JYNT $10.80
  • ACHV $4.23
  • Resistance Level
  • JYNT $12.02
  • ACHV $4.64
  • Average True Range (ATR)
  • JYNT 0.45
  • ACHV 0.16
  • MACD
  • JYNT 0.15
  • ACHV 0.03
  • Stochastic Oscillator
  • JYNT 72.09
  • ACHV 72.22

About JYNT The Joint Corp.

The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The Company has two operating business segments; the Corporate Clinics segment is comprised of the operating activities of the company-owned or managed clinics, and The Franchise Operations segment is comprised of the operating activities of the franchise business unit. The company generates maximum revenue from the Corporate clinic's segment.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks: